NKGN NKGen Biotech Inc Total Business Assets
The price action on this chart reflects the total asset dynamics of NKGen Biotech, Inc. (NKGN), which develops cell-based therapies for dementia and Parkinson's disease in the elderly, with the indicator standing at 0.00. The company currently operates as a cash-burn entity, as it has yet to launch commercial products. Global behemoths that have already captured market share and possess certified medications pose significant risks.
Analytical breakdowns and data insights for company NKGen (NKGN)
- stock quotes and analyst forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio NKGen Biotech, Inc.|NKGN - Long-Term Debt to Equity|Current Liabilities to Capital NKGen Biotech Corp|NKGN - Company Debts|Debt to Book Value Ratio NKGen Biotech Corp|NKGN - Company Long-Term Debt|Company Short-Term Debts NKGen Biotech|Critical Liquidity nkgenbiotech.com
- company profitability and valuation multiples indicators:
Basic company analysis:nkgenbiotech.com
When constructing a long-term portfolio, screening the resource base is critical, where the total asset value—reverse-calculated via ROA as the sum of liabilities and equity—determines the scale of operational potential. For NKGen Biotech (NKGN), this metric reflects the value of proprietary cell therapies and complex biosyntheses that create monolithic barriers to entry, making total asset dynamics a key indicator of business resilience.
Main competitors
Total Business Assets BIIB|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|Aggregate Company Assets Biohaven Ltd.|Total Business Assets AMLX (amylyx.com)|Aggregate Company Assets Trevi Therapeutics, Inc. (TRVI)|Company Total Assets Praxis Precision Medicines Inc (PRAX)|Company Total Assets AVXL (Anavex Corp)|Company Balance Sheet Assets CeriBell EEG|Prothena Corporation plc - Company Total Assets|Company Assets Alector, Inc.|Annexon (ANNX) - Aggregate Company Assets|Total Business Assets OMER|Cumulative Company Assets NGNE|ACIU: Aggregate Asset Value|Company Total Assets VYGR|Aggregate Company Assets NMRA (neumoratx.com)|Company Total Assets SCLX (Scilex)|Company Total Asset Base Tevogen Bio Holdings Inc. (TVGN)|ACOG - Aggregate Company Assets|Company Assets Cognition Therapeutics Inc.|IKT (Inhibikase Therapeutics) - Cumulative Company Assets|SAVA: Aggregate Business Assets|ASRT (Assertio Holdings) - Company Total Assets|Company Assets Coya COYA|Company Total Assets VTGN|Cumulative Company Assets ovidrx.com OVID|Company Total Assets ABOS (Acumen Pharmaceuticals)|Aggregate Asset Value CRVO|ATHE: Cumulative Company Assets|Aggregate Asset Value CLNN (Clene Inc.)|PEPG: Company Total Assets|JUNS - Company Total Asset Base|Aggregate Company Assets Relmada Therapeutics|Total Business Assets ANVS (annovisbio.com)|Company Total Assets GRCE|Cumulative Company Assets Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences - Cumulative Company Assets|Company Total Asset Base NeuroSense Therapeutics Ltd (NRSN)|RVPH - Aggregate Company Assets|MTVA (MetaVia Inc) - Total Business Assets|NeurAxis (NRXS) - Aggregate Company Assets|Helius Medical Technologies (HSDT) - Company Total Assets|PASG (Passage Bio Inc.) - Company Total Assets|NEUP - Company Balance Sheet Assets|Aggregate Company Assets Minerva Neurosciences (NERV)|athira.com - Total Business Assets|Aggregate Company Assets Addex Therapeutics Ltd ADXN|ALZN: Total Business Assets|Cyclerion - Company Total Assets|Company Assets Protagenic Therapeutics|KTTA (pasitheaclinics.com) - Cumulative Company Assets|Cortigent (CRGT) - Company Total Assets|Aggregate Company Assets Avenue Therapeutics, Inc.|BCLI: Aggregate Asset Value|Aggregate Company Assets Cara Therapeutics, Inc (CARA)|CHRO - Company Assets|Aggregate Company Assets Eliem Therapeutics Inc. ELYM|ITCI: Total Business Assets|LBPH - Aggregate Company Assets|MRNS - Company Total Assets|NRBO: Company Total Assets|Company Balance Sheet Assets Sage Therapeutics Inc SAGE|SNPX (Synaptogenix, Inc.) - Company Total Assets|Company Assets trevena.com TRVN|Aggregate Company Assets Vigil Neuroscience (VIGL)|anewmeds.com - Total Business Assets|Cerevel - Cumulative Company Assets